Kurki, Pekka http://orcid.org/0000-0002-7077-0305
Barry, Sean
Bourges, Ingrid
Tsantili, Panagiota
Wolff-Holz, Elena
Funding for this research was provided by:
University of Helsinki including Helsinki University Central Hospital
Article History
Accepted: 30 August 2021
First Online: 1 October 2021
Declarations
:
: PK and EW-H planned the study. IB analyzed the prelicensing safety data; PT analyzed the postmarketing safety data; SB analyzed the administration devices; EW-H analyzed the immunogenicity data; and PK analyzed the interchangeability data. All authors participated in the drafting of the manuscript.
: The opinions expressed in this article are personal views of the authors and may not be understood or quoted as being made on behalf of or reflecting the position of the agencies or organizations with which the authors are affiliated.
: Open access funding provided by University of Helsinki including Helsinki University Central Hospital.
: Pekka Kurki, Sean Barry, Ingrid Bourges, Panagiota Tsantili, and Elena Wolff-Holz have completed the ICMJE uniform disclosure (available upon request) and declare no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; and no other relationships or activities that could appear to have influenced the submitted work.
: Not Applicable.
: Not Applicable.
: All data generated or analyzed during this study are included in this published article (and its supplementary information files).
: Not applicable.